NeuroSense Therapeutics Ltd./$NRSN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
Ticker
$NRSN
Sector
Primary listing
Employees
17
Headquarters
Herzliya, Israel
Website
NRSN Metrics
BasicAdvanced
$25m
-
-$0.44
1.68
-
Price and volume
Market cap
$25m
Beta
1.68
52-week high
$2.52
52-week low
$0.63
Average daily volume
137k
Financial strength
Current ratio
0.309
Quick ratio
0.079
Long term debt to equity
-4.615
Total debt to equity
-10.897
Profitability
EBITDA (TTM)
-11.069
Management effectiveness
Return on assets (TTM)
-247.30%
Return on equity (TTM)
-2,174.98%
Valuation
Price to book
-14.71
Price to tangible book (TTM)
-14.71
Price to free cash flow (TTM)
-2.339
Free cash flow yield (TTM)
-42.75%
Free cash flow per share (TTM)
-0.301
Growth
Earnings per share change (TTM)
-20.46%
3-year earnings per share growth (CAGR)
-21.77%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs